Xconomy Awards Boston →
CEO and Founder, Techstars
Director, Life Sciences Institute, University of Michigan
Founder and Chairman, Sycamore Networks
Software Engineer at Skelmir
VP of Research and Special Initiatives, Google
Nobel Laureate, Professor of Biology, Caltech
July 16, 2019 · Boston
September 11, 2019 · Boston
September 12, 2019 · Boston
Exelixis (NASDAQ: EXEL) is a South San Francisco biotechnology company developing drugs for thyroid cancer, prostate cancer, and other conditions.
From Our Editors · Special Report
Facing an Uncertain Future
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Remain compliant and ensure optimal productivity
See how TAI Diagnostics achieved accelerated growth
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.